Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check4 days agoChange DetectedThe site revision marker in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe 403 Forbidden block was removed, returning the Study Details page to its normal layout. This enables access to the study information for NCT05187182.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-restricted notice and a basic footer. This indicates that the study record is presently inaccessible.SummaryDifference21%

- Check46 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, signaling a small update to the page’s version. This change does not alter the content or how users interact with the study details.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page. This appears to be a small maintenance update and does not modify study details or user-facing features.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version of the page content. This appears to be a maintenance update that does not modify study data or eligibility details.SummaryDifference0.0%

Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.